Targeting epigenetic chromatin modification enzymes upregulated by M2c macrophage polarization with a proteasome inhibitor ixazomib in lung cancer: a novel approach

Copy For Citation

KAYA TİLKİ E., ENGÜR ÖZTÜRK S.

6th European Congress of Immunology, İstanbul, Turkey, 01 September 2021

• Publication Type: Conference Paper / Summary Text
• Doi Number: 10.1002/eji.202170200
• City: İstanbul
• Country: Turkey
• Anadolu University Affiliated: Yes